Treatment and Prevention of Cytomegalovirus Infections

  • Monto Ho


Treatment of systemic virus diseases is still largely experimental, although rapid progress is being made. The basic problem has been that putative antiviral agents may not be effective enough or are too toxic. Evaluation of the effect of these drugs may also be difficult. Frequently, the disease that is treated has a variable course, and the demonstration of efficacy of an antiviral may not be possible except by a blind, controlled study in which the drug-treated group is compared to a placebotreated group. Such studies are expensive to undertake, and although the knowledge gained is usually solid, it is often limited. On the other hand, when a drug seems to be effective, controlled studies are also difficult to undertake.


Renal Transplant Recipient Vaccine Strain Transfer Factor Immune Globulin Seropositive Donor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Monto Ho
    • 1
    • 2
  1. 1.Graduate School of Public Health and School of MedicineUniversity of PittsburghPittsburghUSA
  2. 2.Presbyterian-University HospitalPittsburghUSA

Personalised recommendations